Zynerba Pharma Inc. (ZYNE) stock declines during pre-market session. Here’s what you should know?
Zynerba Pharma Inc. (NASDAQ: ZYNE) stock gained by 4.68% at the last close while the ZYNE stock price falls by 1.06% during the pre-market session. Zynerba Pharmaceuticals is a pioneer of pharmaceutically developed transdermal cannabinoid treatments for neuropsychiatric conditions that are rare or near-rare. What is happening? ZYNE announced on May 17, 2021, that it […]
